Toggle light / dark theme

I am in shock… Google suddenly as yahoo are allowing conjecture and mendacity be seen as public or scientific opinion. Here is another confused mind who towards the end of her rant quotes Christian scripture as basis to stop Life extension-Transhumanism???

When I say to these minds Behold the leader of Christianity stood for Life abundant-Super Longevity and I can prove such. No matter what lost evangelist or preacher tells you Jesus was a medical researcher of extraordinary magnitude…

NOW BEHOLD THE LOST in this article… https://www.rodofironministries.com/…/transhumanism-and-imm… Respect r.p.berry & AEWR wherein aging now ends we have found the many causes of aging and we have located an expensive cure. We search for partners-investors to now join us in agings end… gerevivify.blogspot.com/


Whether we like it or not, the hybrid age is already here. From genetic manipulation, to AI technology, to nano-technology, robotics, 3D printing, brain mapping, super computing, the list is literally endless. Futurists and Transhumanist philosophers believe that science and technology are limitless, and that humanity’s current cultural traditions and mindset are the mechanisms in place that prohibit human development.

Mankind has experienced formidable technological growth in the past from the early ancestors to the Agrarian Age, the Industrial Age in the 18th century, and the Information Age in the 1970s, from their point of view, we are simply going through another revolutionary leap into what they call, the Hybrid Age.

The Transhumanist Movement, also known as H+ is an intellectual, cultural and political movement that supports technological enhancements in the human body through the use of genetics, robotics, synthetic biology, AI technology among others to modify the physiology, psyche, memory and progeny of a human being and ultimately achieve immortality on earth, (a procedure they believe can be reached within the next decade) whereby human consciousness can be uploaded into a robot, cyborg or possibly, a human clone. The sci-fi novel “Altered Carbon” by Richard K. Morgan captures a cornucopia of technological concepts that are, believe it or not, in experimental stages across the globe, methods such as: human hybridization, CRISPR-technology—Chinese scientists have used CRISPR for gene-editing on 86 human patients; limb regeneration, bionic augmentation, the making of super-soldiers, cloning, Cryonics and the growing interest in information-theoretic death, neuropreservation, suspended animation, molecular nano-technology and so on. Sounds far-fetched right?

The quest to live longer and healthier is not new. But the concept of reversing aging has recently stunned both the scienftific community and the public in general. Scientists have been able to reverse aging by 2.5 years to some participants in a groundbreaking experiment in the field of age reversal.

World leading scientists in the field of aging like David Sinclair think that aging is the ultimate disease that needs a cure. If scientsits were able to shed 2.5 years to the participants genomic age, the question raises itself, are we going to see an age reversal of a decade or more in the coming years?

#reverseaging #science #sciencetime

SUBSCRIBE to our channel “Science Time” and ring the bell to never miss out videos like this: https://www.youtube.com/sciencetime24

Source: Fahy, G. M. et al. Aging Cell https://doi.org/10.1111/acel.13028 (2019)

Similar videos:

Amidst rising hopes for using CRISPR gene editing tools to repair deadly mutations linked to conditions like cystic fibrosis and sickle cell disease, a study in Communications Biology describes a new innovation that could accelerate this work by rapidly revealing unintended and potentially harmful changes introduced by a gene editing process.

“We’ve developed a new process for rapidly screening all of the edits made by CRISPR, and it shows there may be many more unintended changes to DNA around the site of a CRISPR repair than previously thought,” said Eric Kmiec, Ph.D., director of ChristianaCare’s Gene Editing Institute and the principle author of the study.

The study describes a new tool developed at the Gene Editing Institute that in just 48 hours can identify “multiple outcomes of CRISPR-directed gene editing,” a process that typically required up to two months of costly and complicated DNA analysis.

Over 116,000 people in the US are on organ transplant waiting lists because of a shortage in healthy donated organs. Dr. Wells and his team have been harnessing the power of stem cells to grow miniature versions of human organs in the laboratory. Today, mini organs are being used to help diagnose patients and improve care and Dr. Wells and colleagues are working to generate lab grown organs for future transplantation into patients. Screen reader support enabled. FB: James Wells, LinkedIn: James Wells As a Developmental Biologist, Jim Wells has spent the past two decades trying to uncover how a single cell gives rise to tissues, organs and eventually a whole organism. With this information as a roadmap, he has pioneered approaches to generate mini organs (organoids) from stem cells in the laboratory. Dr. Wells is now part of a team that is using tissue engineering to generate bigger and more functional organs in the lab that can be used for transplantation into patients in the future. Dr. Wells is a professor of Pediatrics at the Cincinnati Children’s Hospital Medical Center. He is in the Division of Developmental Biology and where he established the human pluripotent stem cell facility. He is also the Director for Basic Research in the Division of Endocrinology and was appointed Chief Scientific Officer of the Center for Stem Cell and Organoid Medicine. As a Developmental Biologist, Jim Wells has spent the past two decades trying to uncover how a single cell gives rise to tissues, organs and eventually a whole organism. With this information as a roadmap, he has pioneered approaches to generate mini organs (organoids) from stem cells in the laboratory. Dr. Wells is now part of a team that is using tissue engineering to generate bigger and more functional organs in the lab that can be used for transplantation into patients in the future. Dr. Wells is a professor of Pediatrics at the Cincinnati Children’s Hospital Medical Center. He is in the Division of Developmental Biology and where he established the human pluripotent stem cell facility. He is also the Director for Basic Research in the Division of Endocrinology and was appointed Chief Scientific Officer of the Center for Stem Cell and Organoid Medicine. This talk was given at a TEDx event using the TED conference format but independently organized by a local community.

Biological weapons could be built which target individuals in a specific ethnic group based on their DNA, a report by the University of Cambridge has warned.

Researchers from Cambridge’s Centre for the Study of Existential Risk (CSER) said the government was failing to prepare for ‘human-driven catastrophic risks’ that could lead to mass harm and societal collapse.

In recent years advances in science such as genetic engineering, and artificial intelligence (AI) and autonomous vehicles have opened the door to a host of new threats.

Researchers in Vienna from Ulrich Elling’s laboratory at IMBA—Institute of Molecular Biotechnology of the Austrian Academy of Sciences—in collaboration with the Vienna BioCenter Core Facilities have developed a revolutionary CRISPR technology called “CRISPR-Switch,” which enables unprecedented control of the CRISPR technique in both space and time.

CRISPR/Cas9 technology is based on a modified version of a bacterial defense system against bacteriophages. One of the landmark discoveries for this technique in fact was laid in Vienna and published in 2012 in a study co-authored by Emmanuelle Charpentier and VBC Ph.D. student, Krzysztof Chylinski. Due to its power to also edit mammalian genomes, CRISPR/Cas9 has rapidly established itself as the most employed gene editing method in laboratories across the world with huge potential to find its way to the clinics to cure rare disease. Just a week ago, the first success in the treatment of sickle cell anemia was announced.

To control the power of genome editing, several groups have worked on systems to control editing activity. Scientists from the lab of Ulrich Elling at IMBA were now able to gain unprecedented control over sgRNA activity, in a system termed “CRISPR-Switch.” The results are published in the renowned journal Nature Communications.

Human-animal hybrids are set to be developed at the University of Tokyo after the Japanese government recently lifted a ban on the controversial stem-cell research.

Hiromitsu Nakauchi—director for Stem Cell Biology and Regenerative Medicine at the University of Tokyo and team leader at Stanford’s Nakauchi Lab—is the first to receive approval for the questionable experiments which will attempt to grow human cells in rat and mouse embryos before being brought to term in a surrogate animal.

Despite many feeling that such studies are the equivalent of playing God, scientists say that the objective is far from sinister. It’s theorized that developing animals with organs constructed from human cells will create organs that can then be used for transplants in humans, cutting the long organ donation waitlists.

CRISPR-Cas9 is an efficient and versatile tool for genome engineering in many species. However, inducible CRISPR-Cas9 editing systems that regulate Cas9 activity or sgRNA expression often suffer from significant limitations, including reduced editing capacity, off-target effects, or leaky expression. Here, we develop a precisely controlled sgRNA expression cassette that can be combined with widely-used Cre systems, termed CRISPR-Switch (SgRNA With Induction/Termination by Cre Homologous recombination). Switch-ON facilitates controlled, rapid induction of sgRNA activity. In turn, Switch-OFF-mediated termination of editing improves generation of heterozygous genotypes and can limit off-target effects. Furthermore, we design sequential CRISPR-Switch-based editing of two loci in a strictly programmable manner and determined the order of mutagenic events that leads to development of glioblastoma in mice. Thus, CRISPR-Switch substantially increases the versatility of gene editing through precise and rapid switching ON or OFF sgRNA activity, as well as switching OVER to secondary sgRNAs.